KMT2A and leukemia: As to MLL-r ALL enriched in infant ALL patients, a study in 2012 conducted by Ross et al. showed that MLL-r leukemia had much lower RAF of rs10821936 than those without such translocation, revealing a significant risk with rs10821936 among ALL/MLL-germline cases only (Ross et al., 2013).